15297421

Source:http://linkedlifedata.com/resource/pubmed/id/15297421

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017262, umls-concept:C0032854, umls-concept:C0079419, umls-concept:C0174680, umls-concept:C0185117, umls-concept:C0205210, umls-concept:C0249197, umls-concept:C0440743, umls-concept:C0677886, umls-concept:C0681890, umls-concept:C1274040, umls-concept:C1561558, umls-concept:C2911684
pubmed:issue	15
pubmed:dateCreated	2004-8-6
pubmed:abstractText	Dysregulation of cell cycle control, in particular G(1)-S-phase transition, is implicated in the pathogenesis of most human cancers, including epithelial ovarian cancer (EOC). However, the prognostic significance of aberrant cell cycle gene expression in EOC remains unclear.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/CDKN1A protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cell Cycle Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin D1, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin E, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor..., http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1078-0432
pubmed:author	pubmed-author:BaliAnishA, pubmed-author:EdwardsLyndal SLS, pubmed-author:HackerNeville FNF, pubmed-author:HenshallSusan MSM, pubmed-author:O'BrienPhilippa MPM, pubmed-author:SutherlandRobert LRL
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	10
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5168-77
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15297421-Cell Cycle, pubmed-meshheading:15297421-Cell Cycle Proteins, pubmed-meshheading:15297421-Cell Line, Tumor, pubmed-meshheading:15297421-Cyclin D1, pubmed-meshheading:15297421-Cyclin E, pubmed-meshheading:15297421-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:15297421-Cystadenocarcinoma, Serous, pubmed-meshheading:15297421-Disease Progression, pubmed-meshheading:15297421-Disease-Free Survival, pubmed-meshheading:15297421-Female, pubmed-meshheading:15297421-Gene Expression Regulation, Neoplastic, pubmed-meshheading:15297421-Humans, pubmed-meshheading:15297421-Immunohistochemistry, pubmed-meshheading:15297421-Odds Ratio, pubmed-meshheading:15297421-Ovarian Neoplasms, pubmed-meshheading:15297421-Proportional Hazards Models, pubmed-meshheading:15297421-Risk, pubmed-meshheading:15297421-Time Factors, pubmed-meshheading:15297421-Treatment Outcome, pubmed-meshheading:15297421-Tumor Markers, Biological, pubmed-meshheading:15297421-Tumor Suppressor Protein p53
pubmed:year	2004
pubmed:articleTitle	Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
pubmed:affiliation	Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't